Amphastar (AMPH) Reports Q2 Earnings: What Key Metrics Have to Say

For the quarter ended June 2025, Amphastar Pharmaceuticals (AMPH) reported revenue of $174.41 million, down 4.4% over the same period last year. EPS came in at $0.85, compared to $0.94 in the year-ago quarter.The reported revenue compares to the Zacks Consensus Estimate of $169.84 million, representing a surprise of +2.69%. The company delivered an EPS surprise of +19.72%, with the consensus EPS estimate being $0.71.While investors closely watch year-over-year changes in headline numbers -- revenue and earn ...